Helsinn Group and MEI Pharma Report Correlation between Mutations in DNA Methylation Pathway and Clinical Response in Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
Analysis shows statistically significant CR rate (p=0.027) in patients with mutations in DNA methylation pathway, includ…